Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
A Phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of paltusotine treatment vs placebo as well as the long-term safety of paltusotine in adults with carcinoid syndrome due to well-differentiated neuroendocrine tumors. The purpose of this study is to continue the evaluation of the safety, efficacy, and pharmacokinetics (PK) of paltusotine in participants with carcinoid syndrome.
Epistemonikos ID: bf6db98b65156fad4580d8b03d4d1de00cd37c82
First added on: Jul 26, 2025